The company believes Ampion™ may be effective in disrupting the COVID-19 inflammatory reaction and improving patient outcomes. David Bar-Or, M.D., Founder of Ampio, spoke about the recent clinical results on a Colorado affiliate FOX news
segment, “Colorado Drug shows promise against COVID-19.”